NGS technologies can detect driver mutations in cancer, including in the genes involved in the homologous recombination (HR) DNA repair pathway, such as BRCA1, BRCA2, PALB2, RAD51C, RAD51D, ATM, CHEK2, BARD1, CDK12, and others. Here, BRCA1 is linked to cancer.